禾榮科 7799
Listed · Biotechnology and medical care432▲+32 (+8%)After close
- Prev close
- 400
- Volume (shares)
- 495,400
- Data time
- 2026-11-11 13:30:00
- Open
- 407.00
- High
- 434.00
- Low
- 407.00
- Prev close
- 400.00
- Volume (lots)
- 495
- Turnover
- 2.09 億
- P/E
- —
- Cash yield
- —
Financial trends
Loading…
Consolidated statements; NT$100M (per-share items in NT$). Updated after each quarterly filing (MOPS). Some line items do not apply to financial companies.
Unit: 100 million TWD (EPS in TWD)Source: public data from MOPS, TWSE, TPEx and TDCC
Loading…
Figures are shown as announced, with no scoring or rating.
| Metric | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | -827.85% | -1,506.35% | -0.59% | -175.62% | -56.54% | -889.04% | 183.84% | — |
| Operating margin | -10,555.76% | -28,243.85% | -3,067.38% | -2,684.00% | -6,637.81% | -4,993.82% | -36,513.54% | — |
| Net margin | -8,161.04% | -21,313.29% | -1,995.77% | -1,726.58% | -6,589.45% | -4,813.83% | -35,653.28% | — |
| ROE (TTM) | -3.15% | -7.67% | -7.16% | -7.43% | — | -24.81% | — | -22.83% |
| ROA (TTM) | -2.97% | -7.44% | -6.96% | -7.34% | — | -23.96% | — | -21.86% |
| EPS, quarter (TWD) | -0.73 | -0.68 | -0.37 | -0.49 | -1.63 | -0.60 | -0.59 | — |
| EPS, TTM (TWD) | -2.27 | -3.17 | -3.09 | -3.31 | — | -2.24 | — | -2.04 |
No data.
Revenue in NT$100M; 12 months per page.
No data.
Amounts in NT$100M (per-share items in NT$).
No data.
Amounts in NT$100M (per-share items in NT$).
No data.
Amounts in NT$100M (per-share items in NT$).
| Metric | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|
| Current ratio | 1,039.35% | 13,575.73% | — | — | — | — | — | — |
| Debt ratio | 10.40% | 2.86% | 2.49% | 0.77% | 0.42% | 3.98% | 4.53% | 4.66% |
| Equity ratio | 89.60% | 97.14% | 97.51% | 99.23% | 99.58% | 96.02% | 95.47% | 95.34% |
| Equity multiplier | 1.12 | 1.03 | 1.03 | 1.01 | 1.00 | 1.04 | 1.05 | 1.05 |
| Metric | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|
| Asset turnover (TTM revenue / avg. assets) | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — | 0.00 |
| Equity turnover | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | — | 0.00 |
Source: MOPS. For reference only; not investment advice.